Evolutionary genomics and experimental evolution drug discovery platform
exploratoryplatform · high
Identify aging- and chronic-disease-relevant pathways and candidate pharmaceuticals using evolutionary biology, quantitative genetics, experimental evolution, genome-wide sequencing, and statistical learning.
Uses experimentally evolved Drosophila populations, genomic sequencing, quantitative genetics, and statistical learning to connect evolved aging phenotypes with drug-discovery targets.
Company site describes the platform and lists supporting scientific papers; no named drug candidates or clinical-stage programs are disclosed in the supplied material.
Supporting publications describe experimental evolution and genomic analyses in Drosophila, but no company-specific therapeutic results are disclosed.